Marcie A. Goldstein

Davis Polk advised the sole book-running manager in connection with Galapagos NV’s offering of 4,312,500 ordinary shares in the form of American depositary shares, which includes the full…

Davis Polk advised the underwriters in connection with the $352.5 million SEC-registered secondary offering of 23,116,416 shares of Class A common stock of Hostess Brands, Inc. by…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a follow-on offering of 5,068,083 shares by Coupa Software Incorporated…

Davis Polk advised the underwriters in connection with a secondary offering of 7,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of Evolent’s existing stockholders…

Davis Polk advised the representatives of the underwriters in connection with the $75.9 million offering of 3,700,000 shares of common stock of REGENXBIO Inc. The common stock is listed on…

Davis Polk advised the active joint book-running managers and representatives of the underwriters in connection with the $90 million follow-on offering of 4,000,000 shares of common stock…

Davis Polk advised the joint book-running managers in connection with the $218.5 million initial public offering of 13,656,250 shares of Class A common stock of Hamilton Lane…

Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with the $349 million secondary offering of 10,989,163 common shares of The…

Davis Polk advised the joint book-running managers in connection with the $125 million public offering of common stock of Coherus BioSciences, Inc. The common stock is listed on the NASDAQ…

Davis Polk advised the lead book-running manager and representative of the underwriters in connection with its $101.9 million initial public offering of common stock of Jounce Therapeutics,…